In a report issued on May 4, Colleen M. Kusy from Robert W.
The post Jounce Therapeutics (JNCE) Receives a Buy from Robert W. Baird appeared first on Smarter Analyst.
In a report issued on May 4, Colleen M. Kusy from Robert W. Baird maintained a Buy rating on Jounce Therapeutics (JNCE), with a price...

https://www.smarteranalyst.com/new-blurbs/jounce-therapeutics-jnce-receives-a-buy-from-robert-w-baird/

#SmarterAnalyst